Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.2K
3.2K
Cancer02:18

Cancer

55.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.0K
6.0K
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes.

Heart (British Cardiac Society)·2026
Same author

Estimating tumour immune infiltration: methodological convergence across histology and spatial technologies.

Briefings in bioinformatics·2026
Same author

Generation of spinal cord organoids from human induced pluripotent stem cells caudalised to a lumbar fate.

Scientific reports·2026
Same author

Orchestrating Spatial Transcriptomics Analysis with Bioconductor.

bioRxiv : the preprint server for biology·2025
Same author

Large Language Models for Accessible Reporting of Bioinformatics Analyses in Interdisciplinary Contexts.

bioRxiv : the preprint server for biology·2025
Same author

Insights, opportunities, and challenges provided by large cell atlases.

Genome biology·2025
Same journal

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026
Same journal

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer.

Computational biology and chemistry·2026
Same journal

In silico characterization of acetyl-CoA carboxylase from Staphylococcus aureus and Escherichia coli: A comparative analysis.

Computational biology and chemistry·2026
Same journal

An optimized cascaded transformer with progressive attention for lung and colon cancer diagnosis from histopathological images.

Computational biology and chemistry·2026
Same journal

From cross cancer transcriptomics to therapeutics: WGX-50 target hub genes in breast cancer and non-small cell lung carcinoma.

Computational biology and chemistry·2026
Same journal

Blood-based biomarker discovery through integrative transcriptomic and miRNA network analyses in schizophrenia, major depressive disorder, and bipolar disorder.

Computational biology and chemistry·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K

Characterizing mutation-expression network relationships in multiple cancers.

Shila Ghazanfar1, Jean Yee Hwa Yang2

  • 1School of Mathematics and Statistics at the University of Sydney, F07, The University of Sydney, NSW 2006, Australia; Data61, CSIRO, Locked Bag 17, North Ryde, NSW 2113, Australia.

Computational Biology and Chemistry
|March 4, 2016
PubMed
Summary
This summary is machine-generated.

This study reveals that while cancer mutations are common across different cancer types, their effects on gene expression networks vary significantly. This finding may help identify cancers with similar network behaviors for tailored therapies.

Keywords:
Gene expressionMutationPan-cancerProtein–protein interaction network

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

8.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

8.0K

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Large cancer datasets, such as The Cancer Genome Atlas, offer rich information for cross-cancer studies.
  • Network approaches have identified complex interrelationships between mutational and expression profiles but lack direct testing for mutation-driven expression changes.
  • A pan-cancer study is needed to integrate mutation and gene expression data by analyzing networks associated with specific mutations.

Purpose of the Study:

  • To develop and apply an integrative framework for analyzing mutation and gene expression data across multiple cancer types.
  • To investigate commonalities and differences in mutation-expression networks among 19 distinct cancers.
  • To identify potential therapeutic strategies by uncovering similarities in mutation-associated network behavior.

Main Methods:

  • Generated cancer-specific mutation-expression networks using somatic mutation and gene expression data from 19 cancers.
  • Evaluated network enrichment for known cancer-related genes.
  • Analyzed concordance of gene expression changes associated with commonly mutated genes across cancers.
  • Compared network overlap based on non-silent mutation load.

Main Results:

  • Generated mutation-expression networks were significantly enriched for known cancer genes.
  • Identified common mutations across cancers but limited concordance in associated gene expression changes.
  • Observed greater network overlap in cancers with higher non-silent mutation loads.

Conclusions:

  • The developed framework enables network exploration via co-analysis of somatic mutations and gene expression.
  • While mutations are common, their impact on gene expression networks varies significantly across cancer types.
  • Identified similar mutation-associated network behaviors in certain cancers, suggesting potential for shared therapeutic strategies.
  • Integrated framework and visualizations available in the PAn Cancer Mutation Expression Networks (PACMEN) R Shiny application.